Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?


Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on March 13, 2022 19:26 (3M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 266653556 series 2740117
By MasterMedFacts LLC, Dr RR Baliga, MD, and MBA. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians


Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343

Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion

246 episodes